Key facts
- It has raised $7.1M; the latest was Seed Round ($7.1M) in Feb 2026.
- Notable investors include IBB Ventures, Tepass Capital, 22 Ventures, EquityPitcher Ventures, zwei.7 Holding.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Hellomed
- ·The full record, as it builds
Funding rounds
No funding rounds for Hellomed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hellomed
Developer of an online pharmacy platform designed to deliver all the medications as per prescription. The company's platform safely pre-sorts medications by day and time of administration, delivers them to a desired address, helps to create an individual medication plan, and offers urgent and primary medical care for the whole family in a friendly, comfortable atmosphere, enabling chronic patients, caregivers, and ambulant care workers with a carefree experience for prescription and medication management.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2022
- Employees
- 20
- Website
- hellomed.com/
- Ownership
- Privately Held (backing)
Hellomed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hellomed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hellomed in its N-PORT filings yet. We sweep new filings monthly.